Cardiovascular CDMOs

LTS Lohmann Therapie-Systeme

Germany

LTS Lohmann Therapie-Systeme AG is a leading CDMO specializing in non-invasive drug delivery systems for nearly 40 years. They are platform specialists in Transdermal Therapeutic Systems (TTS), Oral Thin Films (OTF), and Microneedle Array Patches (MAP). Their full-service CDMO offer covers the entire product lifecycle from API evaluation and feasibility through prototyping, clinical trial supply, and commercial-scale manufacturing. They have manufactured transdermal systems for nicotine, nitroglycerin, and hormone patches, as well as platforms for Parkinson's, Alzheimer's, and pain management.

Macleods Pharmaceuticals Ltd

India

Macleods Pharmaceuticals Ltd is one of India's top 10 pharmaceutical companies, operating as a CDMO for developing, manufacturing, and globally distributing pharmaceutical products. They produce diverse dosage forms including solid orals, liquid orals, topical formulations, injectables, metered dose inhalers, and dry powder inhalers across therapeutic areas including anti-TB, antimalarials, antiretrovirals, antidiabetics, antihypertensives, and antiasthmatics. They have 152 FDA-approved products, WHO prequalified medicines, and manufacturing facilities compliant with UK MHRA, US FDA, TGA, and WHO guidelines. They operate in 100+ countries.

Nectar Lifesciences Ltd.

India

Indian pharmaceutical company with vertically integrated API and formulation manufacturing. FDA registered with 2 FEI numbers (operations: ANALYSIS, API, FDF). Offers CDMO services alongside own branded products. Manufactures both APIs (including beta-lactam antibiotics) and finished dosage forms across oral solids, injectables, and lyophilized products.

Suzhou Lixin Pharmaceutical Co., Ltd. is a privately-owned Chinese GMP manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and intermediates, established in 2000. The company produces APIs including semaglutide, sitagliptin phosphate, and indapamide, with multiple FDA-registered facilities that have been FDA-inspected.

Corning Incorporated (Life Sciences & Pharmaceutical Technologies)

India

Corning Incorporated's Pharmaceutical Technologies division manufactures advanced glass packaging solutions for the pharmaceutical industry, most notably Valor Glass vials and containers designed for drug storage and delivery. The company is a materials science and glass technology company, not a drug manufacturer or CDMO.

Flagship Biotech International is an Indian pharmaceutical company headquartered in Mumbai with manufacturing facilities across India (Tarapur, Navsari, Naroda, Baddi). It manufactures a broad range of pharmaceutical dosage forms including tablets, capsules, injectables, LVP, SVP, inhalers, ointments, and suppositories for its own brands and contract manufacturing for organizations globally in 45+ countries.

Guangdong Blue Treasure Pharmaceuticals is a Chinese joint venture pharmaceutical company founded in 1994, part of the Livzon Pharmaceutical Group, specializing in the production of APIs including Pravastatin Sodium (cardiovascular), Mycophenolic Acid (immunosuppressant), and Compactin/Mevastatin. The company operates multiple FDA-registered API manufacturing sites with a strong inspection history.

Kekule Pharma Limited

India

Kekule Pharma Limited is a Hyderabad-based API and pharmaceutical intermediates manufacturer in India. Specializes in developing novel (patent non-infringing) processes for API synthesis. Offers custom synthesis, contract manufacturing, scale-up from kgs to tons, impurity synthesis, and regulatory documentation (DMFs in CTD format). Extensive product portfolio including oncology APIs (Capecitabine, Temozolomide, Imatinib, Gefitinib, Bortezomib), CNS (Escitalopram, Citalopram), GI (Pantoprazole, Famotidine), and others. FDA registered with 2 FEI numbers, 3 inspections (3 VAI).

Laboratoires Théa

France

Laboratoires Thea is an independent French pharmaceutical company based in Clermont-Ferrand, 100% dedicated to ophthalmology. They are Europe's leading independent eye-care group, specializing in researching, developing, manufacturing, and commercializing ophthalmic products including preservative-free eye drops and drug delivery systems for glaucoma, dry eye, allergies, infections, inflammation, and retinal disorders. They are present in 70+ countries and have partnerships with companies like LENZ Therapeutics, Novaliq, and ProQR. While they manufacture their own products, they are a branded pharmaceutical company, not a CDMO or contract manufacturer.

Loxim Industries Limited

India

Loxim Industries Limited is an Indian chemical manufacturing company (founded 1977) with divisions in Dyes, Engineering Plastics, and Pharmaceuticals. The pharmaceutical division manufactures APIs including Montelukast and Dabigatran. Primarily a chemical manufacturer with a pharma API segment, serving customers in 30+ countries. Not primarily a contract manufacturer -- manufactures APIs as part of their broader chemical business.

M2i Life Sciences

France

M2i Life Sciences is a French industrial group founded in 2012, specializing in the design, formulation, and production of complex molecules. Their CDMO division focuses on research, development, and production of active pharmaceutical ingredients (APIs), synthesis intermediates, specialty molecules, and pheromones. They operate across human health, animal health (veterinary formulation and microencapsulation), and biocontrol segments. They produce approximately 1,000 tonnes per year of reference products in pain relief, fever control, and cardiology for France and North Africa.

Indian pharmaceutical CDMO specializing in pre-finished formulation intermediates (PFI) and finished dosage forms (FDF). Manufactures oral solids, oral liquids, injectables, ophthalmics, topicals, and inhalation products. Strong focus on pellet technology and nanotechnology-based drug delivery systems. CRAMS (Contract Research and Manufacturing Services) provider.

NAM Group of Industries Pvt. Ltd.

India

Indian WHO-GMP certified manufacturer and exporter of pharmaceutical active pharmaceutical ingredients (APIs) for human and veterinary use, plus pharmaceutical intermediates and phase transfer catalysts. Not a contract manufacturer -- produces and sells own API portfolio. Headquartered in Mumbai with manufacturing plant in Ankleshwar, Gujarat. Facility covers 5,000 sqm with dedicated clean rooms for human and veterinary APIs.

Nanjing Sino Pharmaceutical Ltd.

China

Chinese pharmaceutical company specializing in production, R&D, and export of generic medicines globally. Covers 1,000+ products across antibiotic, antimalarial, analgesic-antipyretic, cardiovascular, respiratory, antiviral/anti-cancer, hormone, and other therapeutic categories. 20+ years of international registration and export experience in dozens of countries. FDA registered with 3 FEI numbers.

SteriMax Inc.

Canada

SteriMax Inc. is a family-owned Canadian specialty pharmaceutical company based in Oakville, Ontario. They develop, source, manufacture, market, and distribute essential hospital and retail pharmacy products to the Canadian healthcare market. Their portfolio includes generic and branded products across sterile injectables, oral solids, and other essential products. SteriMax has a Health Canada-approved QC lab and their products are manufactured in Health Canada, FDA, or EMEA approved facilities. While they have some internal pharmaceutical manufacturing capabilities (their website mentions production and manufacturing), their primary model appears to be sourcing, marketing, and distributing pharmaceutical products in Canada rather than offering contract manufacturing services to third parties. They are not positioned as a CDMO/CMO.

Berlin‑Chemie (Menarini Group)

Germany

Berlin-Chemie is a subsidiary of the Menarini Group, a global pharmaceutical company focused on developing and marketing its own branded pharmaceutical products across therapeutic areas including cardiovascular, respiratory, diabetes, dermatology, and gastroenterology. It is a proprietary pharma company with its own production facilities, not a contract manufacturer. No evidence of CDMO/CMO services offered to third parties.